Related Articles
The TLR4/ERK/PD‑L1 axis may contribute to NSCLC initiation
Preliminary mechanisms of regulating PD‑L1 expression in non‑small cell lung cancer during the EMT process
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence
PD‑L1 promotes head and neck squamous cell carcinoma cell growth through mTOR signaling